Meril Life Sciences Private Limited

Meril Life Sciences Private Limited - healthcare in Vapi, Gujarat, India. FY 2026 financials & compliance.
CIN U24239GJ2007PTC051137 Incorporated 19 June 2007 ROC Ahmedabad HQ Vapi, Gujarat, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹1,729.52 Cr
▲ 44% YoY
Net profit · FY 2025
₹425.45 Cr
Net margin 24.6%
EBITDA · FY 2025
₹646.12 Cr
EBITDA margin 37.4%
Authorised capital
₹100 Cr
Registered with MCA
Paid-up capital
₹99.36 Cr
Issued & subscribed
Open charges
₹788.45 Cr
Satisfied ₹228.76 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
1,584
Provident fund records

About Meril Life Sciences Private Limited

Data last updated:

Meril Life Sciences Private Limited is a private limited company based in Vapi, Gujarat, India, a subsidiary of Micro Life Sciences Private Limited. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 19 June 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2007PTC051137. Its GSTIN is 24AAFCM1444G1ZT (Gujarat). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹99.36 Cr. It is led by directors including Nanubhai Premjibhai Bambharolia (Whole-Time Director) and Rajnikant Gandalal Vyas (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bilakhia House Survey No. 135/139 Muktanand Marg Chala, Vapi, Gujarat, India – 396191.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,729.52 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹425.45 Cr (net margin 24.6%) and EBITDA of ₹646.12 Cr (EBITDA margin 37.4%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 32% over five years.

The company has about 1,584 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 4 brands: Myval, Misso, Merilvet and Meril. As per MCA filings, the company has open charges of ₹788.45 Cr and satisfied charges of ₹228.76 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 2 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹113.05 Cr; the latest was in March 2023. Its 3 peer companies in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities) are compared by revenue, 3 smaller; the largest is Becton Dickinson India Private Limited. with revenue of ₹1,621.05 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2024, listing 132 overdue payments to 25 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website merillife.com.

Company details

CIN U24239GJ2007PTC051137
Registration Number 051137
Incorporation Date 19 June 2007
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Micro Life Sciences Private Limited
Compliance Status Active Compliant

Contact details

Meril Life Sciences Private Limited's registered office is in Vapi, Gujarat. Its website is merillife.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Bilakhia House Survey No. 135/139 Muktanand Marg Chala, Vapi, Gujarat, India – 396191
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Meril Life Sciences Private Limited, buy the company report.

Comprehensive company report
Meril Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Meril Life Sciences operates multiple associated brands including Myval, Misso, and Merilvet. Each brand links to its own profile.

BrandDescriptionWebsite
Offers a transcatheter aortic heart valve replacement system.myval.com
MISSO provides robotic assistance for accurate joint replacements using 3D scans.misso.ai
Medical device innovation in orthopedics, endo-surgery, and diagnostics.merilvet.com
Developer of medical devices for surgeries and diagnosismerillife.com

Business activity

The main business activity of Meril Life Sciences is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities

To see the full business activity and turnover split of Meril Life Sciences Private Limited, buy the company report.

Financials of Meril Life Sciences Private Limited

FY 2025 filings available

Meril Life Sciences Private Limited reported revenue of ₹1,729.52 Cr (up 44% YoY) for FY 2025.

Revenue · FY 2025
₹1,729.52 Cr ▲ 44%
Net profit · FY 2025
₹425.45 Cr margin 24.6%
EBITDA · FY 2025
₹646.12 Cr margin 37.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 44%
3 years · compounded
▲ 52%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▲ 107%
3 years · compounded
▲ 79%
5 years · compounded
▲ 46%

Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 44% growth in the latest year. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1,729.52 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹646.12 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹425.45 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin37.4%
Net Profit Margin24.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Meril Life Sciences Private Limited, buy the company report.

Board of directors of Meril Life Sciences Private Limited

Meril Life Sciences has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nanubhai Premjibhai BambharoliaWhole-Time Director19 Jun 200719 Years 4 MonthsCurrent
Rajnikant Gandalal VyasWhole-Time Director20 Oct 201016 Years 0 MonthsCurrent
Hemchandra Yadunandan PanjikarDirector11 Mar 20233 Years 7 MonthsCurrent

Peer comparison

Meril Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Meril Life Sciences Private Limitedthis company₹1,729.52 Cr (FY 2025)₹425.45 Cr24.6%44.0%1,584Vapi, Gujarat, India
Becton Dickinson India Private Limited.₹1,621.05 Cr (FY 2025)19.0%New Delhi, Delhi, India
Meril Healthcare Private Limited₹1,411.5 Cr (FY 2025)20.0%Vapi, Gujarat, India
Borosil Limited₹1,134.78 Cr (FY 2025)18.0%Mumbai, Maharashtra, India

To see the full peer comparison of Meril Life Sciences Private Limited, buy the company report.

Auditor

Meril Life Sciences Private Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2025.

Auditor firmFinancial yearFirm registration number
DELOITTE HASKINS & SELLS LLPFY 2025117366W/W-100018

Shareholding

The shareholding of Meril Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Meril Life Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹788.45 Cr
Satisfied charges
₹228.76 Cr
Breakdown by lending institutions
Others₹420.00 Cr
Axis Bank Limited₹149.45 Cr
Hdfc Bank Limited₹120.00 Cr
Standard Chartered Bank₹60.00 Cr
Dbs Bank Ltd₹20.00 Cr
Others₹19.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Nov 2024101013269Others₹144 CrOpen
13 Jun 2023100738279Others₹146 CrOpen
28 Sep 2021100487012Others₹110 CrOpen
25 Jun 2019100273444Hdfc Bank Limited₹120 CrOpen
07 Jun 2019100270162Others₹20 CrOpen

To see the full charge records of Meril Life Sciences Private Limited, buy the company report.

Total charge records: 15 View all charges

Deals & funding

Meril Life Sciences Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹113.05 Cr; the latest was in March 2023.

Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹113.05 Cr

Deals on record (4 of 6)

WhenDealAmountParties
Mar 2023Secondary share transferUndisclosedBuyer: Micro Life Sciences Private Limited
Seller: M3 Investments
Mar 2011Funding round₹58.35 CrInvestors: Micro Life Sciences Private Limited
Mar 2011Secondary share transferUndisclosedBuyer: Micro Life Sciences Private Limited
Seller: an individual
Oct 2008Funding round₹1 CrInvestors: an individual

To see the full deal history of Meril Life Sciences Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Meril Life Sciences Private Limited was last rated by Care on 27 Sep 2022.

Rating agencyRated onRating
Care27 Sep 2022

To see the full credit ratings and regulatory alerts of Meril Life Sciences Private Limited, buy the company report.

MSME payment delays

Meril Life Sciences Private Limited has 5 MSME Form 1 returns on record between 2019 and 2024, listing 132 overdue payments to 25 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 25)

SupplierAmount dueDue sinceReported on
Databank Computer Services
Bombay Tools Supplying Agency
Prakash Teleservices Private Limited
an individual supplier
Life Line Surgichem (India) Private Limited

To see the full MSME payment records of Meril Life Sciences Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Meril Life Sciences has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Meril Life Sciences India Private LimitedU33110GJ1999PTC060787

To see the full group structure of Meril Life Sciences Private Limited, buy the company report.

Employees & EPFO

Meril Life Sciences Private Limited has a workforce of 1,584 employees on its EPFO records as of Sep 25, 2025, across 1 active EPFO establishment.

Employee count
1,584
Active EPFO establishments
1
Employee growth
7.98%

GST

Meril Life Sciences has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
24AAFCM1444G1ZTGujaratActive01 Jul 2017
27AAFCM1444G1ZNMaharashtraActive22 Aug 2017

To see the full GST registrations and return filing status of Meril Life Sciences Private Limited, buy the company report.

Recent activity

Meril Life Sciences Private Limited has 10 board changes on record since 2007: 3 appointments and 7 cessations. The latest: Hemchandra Yadunandan Panjikar ceased to be Additional Director on 08 Sep 2023.

AGM
Meril Life Sciences Private Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records.
Filing
Meril Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 144.00 Cr with Charge ID 101013269 was registered on 15 Nov 2024.
Charges
A charge registered on 24 May 2021 via Charge ID 100450226 with Others was fully satisfied on 19 Jul 2024.
Charges
A charge with Others of Rs. 20.00 Cr registered on 07 Jun 2019 with Charge ID 100270162 was modified on 29 Jun 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 120.00 Cr registered on 25 Jun 2019 with Charge ID 100273444 was modified on 04 Jun 2024.
Charges
A charge with Others of Rs. 110.00 Cr registered on 28 Sep 2021 with Charge ID 100487012 was modified on 25 Jan 2024.
Charges
A charge with Axis Bank Limited of Rs. 149.45 Cr registered on 12 Dec 2013 with Charge ID 10468796 was modified on 14 Dec 2023.
Charges
A charge registered on 10 Sep 2018 via Charge ID 100206576 with Others was fully satisfied on 29 Sep 2023.
Charges
A charge with Others of Rs. 146.00 Cr registered on 13 Jun 2023 with Charge ID 100738279 was modified on 22 Sep 2023.
Ceased
Hemchandra Yadunandan Panjikar ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 146.00 Cr with Charge ID 100738279 was registered on 13 Jun 2023.

30 earlier events are in the company report.

Frequently asked questions

Meril Life Sciences is an active private limited company based in Vapi, Gujarat, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 19 June 2007 (19+ years old) and is registered under CIN U24239GJ2007PTC051137.

Meril Life Sciences has 3 current directors:

The latest financial statements of Meril Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 July 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Meril Life Sciences is 24AAFCM1444G1ZT, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAFCM1444G1ZN (Maharashtra).

The CIN (Corporate Identification Number) of Meril Life Sciences is U24239GJ2007PTC051137. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Meril Life Sciences has 8 court cases on record: 2 filed by the company and 6 filed against it. 2 are pending. Most are in the high courts.

Meril Life Sciences was incorporated on 19 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Meril Life Sciences has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹113.05 Cr; the latest was in March 2023.

The peers of Meril Life Sciences by revenue are Becton Dickinson India Private Limited, Meril Healthcare Private Limited, Borosil Limited, all in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities).

Hemchandra Yadunandan Panjikar ceased to be Additional Director on 08 Sep 2023. Hemchandra Yadunandan Panjikar was appointed as Director on 11 Mar 2023. Dinesh Jain ceased to be Company Secretary on 07 Mar 2020. Meril Life Sciences has 10 board changes on record in total.

Meril Life Sciences has 5 MSME Form 1 returns on record between 2019 and 2024, listing 132 overdue payments to 25 micro and small suppliers. The latest return was filed on 27 Apr 2024.

Meril Life Sciences can be reached through the website merillife.com. Its registered office is in Vapi, Gujarat, India.